Taysha Gene Therapies, Inc. TSHA Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s book value per share?
- Taysha Gene Therapies, Inc. (TSHA) reported book value per share of $0.58 in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s book value per share changed year-over-year?
- Taysha Gene Therapies, Inc.'s book value per share increased by 182.8% year-over-year, from $0.20 to $0.58.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s book value per share has grown at a -44.2% compound annual growth rate (CAGR), from $14.23 to $0.77.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.